DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 5 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $695,519 | +30.6% | 47,090 | +14.2% | 0.09% | +35.3% |
Q2 2023 | $532,756 | +131444.7% | 41,235 | 0.0% | 0.07% | +25.9% |
Q1 2023 | $405 | -7.7% | 41,235 | 0.0% | 0.05% | -11.5% |
Q4 2022 | $439 | -99.7% | 41,235 | +180.7% | 0.06% | +177.3% |
Q3 2022 | $153,000 | – | 14,690 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 11,771,708 | $115,951,000 | 7.60% |
Chicago Capital, LLC | 5,878,959 | $57,908,000 | 2.26% |
PFM Health Sciences, LP | 2,990,770 | $29,459,000 | 0.92% |
Avidity Partners Management LP | 3,400,000 | $33,490,000 | 0.90% |
MIZUHO MARKETS AMERICAS LLC | 617,358 | $6,081,000 | 0.72% |
Rhenman & Partners Asset Management AB | 750,000 | $7,388,000 | 0.50% |
Jackson Creek Investment Advisors LLC | 115,333 | $1,136,000 | 0.42% |
Rock Springs Capital Management LP | 1,679,921 | $16,547,000 | 0.33% |
FEDERATED HERMES, INC. | 14,243,800 | $140,301,000 | 0.26% |
JACKSON SQUARE CAPITAL, LLC | 80,400 | $792,000 | 0.25% |